Healx will use its AI-based drug discovery tech to analyze proprietary Sanofi compound data and identify potential rare disease targets.

Wolfe Research analyst Alexandria Hammond initiated coverage of Regeneron (REGN) with an Outperform rating and $1,150 price target Published ...

HYDERABAD: IT and Industries Minister D Sridhar Babu on Thursday announced that the Congress government has secured ...

AM(IST)on Thursday in an upbeat market. Mankind Pharma Ltd.(up 4.03 per cent), Gland Pharma Ltd.(up 1.78 per cent), Laurus ...

Sanofi, Breakthrough T1D UK, and Beano have partnered to create a bespoke comic strip to raise awareness of autoimmune Type 1 ...

Attorneys for the school district say that the legal action is in part due to self-funded insurance plans that has possibly ...

The PEGylated Proteins Market is primarily driven by the growing demand for effective drug delivery systems, particularly in the treatment of chronic diseases such as cancer, hepatitis, and rheumatoid ...

If confirmed as the HHS Secretary by the US Senate, RFK Jr will oversee federal agencies that dictate healthcare policy in ...

The Nifty Pharma index closed 0.26 per cent at 21752.00. Benchmark NSE Nifty50 index ended down 26.35 points at 23532.7, ...

2 Top Growth Stocks to Buy on the Dip was originally published by The Motley Fool ...

GSK’s 3 billion pounds sterling peak sales goal for its multiple myeloma drug Blenrep appears increasingly attainable thanks ...

Analysts have set 12-month price targets for BioNTech, revealing an average target of $132.24, a high estimate of $171.00, ...